Despite a challenging CASGEVY launch, high cash burn, and an almost 10% YTD share count growth, CRISPR’s pipeline breadth and ...

CRISPR Therapeutics AG (CRSP) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to ...

Discover why Crispr Therapeutics AG is a strong buy with FDA-approved Casgevy, a promising pipeline, and major growth ...

Crispr Therapeutics AG ( ($CRSP) ) has risen by 9.03%. Read on to learn why. Crispr Therapeutics AG has seen its stock price rise by 9.03% over ...

Here are Cathie Wood’s latest moves.

Palantir stock has gained more than 2,000% since the AI revolution kicked off three years ago.

Valens Semiconductor ("Valens"), a leader in high-performance connectivity, today announced that it will host meetings with customers, analysts and investors at Consumer Electronics Show (CES) 2026 on ...

Turning to valuation, CrowdStrike shares trade at a forward price-to-sales (P/S) multiple of about 22.5 times analysts' ...

The featured stories of conference championships all revolve around the College Football Playoff, and this piece itself will build that direction. First, let's keep perspective. There are only nine ...